You Position: Home > Paper

Efifcacy evaluation of traditional Chinese medicine combined with sorafenib in the treatment of primary ;hepatocellular carcinoma in the middle and late stage

( views:156, downloads:60 )
Author:
No author available
Journal Title:
China Clinical Practical Medicine
Issue:
2
DOI:
10.3760/cma.j.issn.1673-8799.2016.02.002
Key Word:
原发性肝癌;中医药疗法;多层螺旋CT;Primary hepatocellular carcinoma;Chinese medicine treatment;Multi-layer spiral CT

Abstract: Objective Evaluation of the treatment effects between sorafenib soley and by combination of SLFN and Chinese Medicine on mid to later phase hepatic carcinomas patients. Methods Take 48 mid to later phase hepatic carcinomas patients of our hospital from 2010 to 2015. Randomly assign 24 patients to sorafenib group and 24 to sorafenib combine Chinese medicine group. To compare the change of their liver function and multilayer spiral MSCT image. Results There were no significant statistical difference between the two groups on size of the tumors, liver diffusion outside, cancer embolus of portal vein(P>0.05). But there were meaningful statistical difference on TBIL, DBIL, ALT, ALB and GLB(P<0.05). Conclusions Compare to chemotherapy only method, there are no different results on tumor growth and diffusion by combing with Chinese Medicine with sorafenib, but there are some effect on improving liver function and life quality.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn